These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 6579324)
1. Lymphocyte transformation test in lepromatous leprosy patients and their healthy siblings. Sengupta SR; Yemul VL; Dhole TN Lepr India; 1983 Apr; 55(2):261-4. PubMed ID: 6579324 [TBL] [Abstract][Full Text] [Related]
2. In-vitro lymphoproliferative response to Mycobacterium leprae of HLA-D-identical siblings of lepromatous leprosy patients. Stoner GL; Touw J; Belehu A; Naafs B Lancet; 1978 Sep; 2(8089):543-7. PubMed ID: 79915 [TBL] [Abstract][Full Text] [Related]
3. In vitro lymphocyte stimulation in patients with lepromatous and borderline tuberculoid leprosy. The effect of dapsone treatment on the response to Mycobacterium leprae antigens, tuberculin purified protein derivative and non-mycobacterial stimulants. Reitan LJ; Closs O; Belehu A Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):455-67. PubMed ID: 6763003 [TBL] [Abstract][Full Text] [Related]
4. Natural suppressor cells in human leprosy: the role of HLA-D-identical peripheral lymphocytes and macrophages in the in vitro modulation of lymphoproliferative responses. Nath I; Van Rood JJ; Mehra NK; Vaidya MC Clin Exp Immunol; 1980 Nov; 42(2):203-10. PubMed ID: 6451335 [TBL] [Abstract][Full Text] [Related]
5. Studies on the defect in cell-mediated immunity in lepromatous leprosy using HLA-D-identical siblings. Absence of circulating suppressor cells and evidence that the defect is in the T-lymphocyte, rather than the monocyte, population. Stoner GL; Mshana RN; Touw J; Belehu A Scand J Immunol; 1982 Jan; 15(1):33-48. PubMed ID: 6176016 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of cell mediated immunity in the histopathologic spectrum of leprosy using lymphocyte transformation test. Job CK; Chacko CJ; Taylor PM; Daniel M; Jesudian G Int J Lepr Other Mycobact Dis; 1976; 44(1-2):256-66. PubMed ID: 776862 [TBL] [Abstract][Full Text] [Related]
7. Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-typed leprosy patients and healthy controls. Klatser PR; Janson AM; Thole JE; Buhrer S; Bos C; Soebono H; de Vries RR Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):178-89. PubMed ID: 9251589 [TBL] [Abstract][Full Text] [Related]
8. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients. Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181 [TBL] [Abstract][Full Text] [Related]
9. Evidence for the presence of M. leprae reactive T lymphocytes in patients with lepromatous leprosy. Nath I; Sathish M; Jayaraman T; Bhutani LK; Sharma AK Clin Exp Immunol; 1984 Dec; 58(3):522-30. PubMed ID: 6391762 [TBL] [Abstract][Full Text] [Related]
10. In vitro studies on the effect of levamisole in lepromatous leprosy. Birdi TJ; Mistry NF; Mahadevan PR; Antia NH J Clin Lab Immunol; 1984 Feb; 13(2):93-6. PubMed ID: 6374154 [TBL] [Abstract][Full Text] [Related]
11. HLA and leprosy in the pre and postgenomic eras. Geluk A; Ottenhoff TH Hum Immunol; 2006 Jun; 67(6):439-45. PubMed ID: 16728267 [TBL] [Abstract][Full Text] [Related]
12. Leprosy reactions: humoral and cellular immune responses to M. leprae, 65kDa, 28kDa, and 18 kDa antigens. Mohanty KK; Joshi B; Katoch K; Sengupta U Int J Lepr Other Mycobact Dis; 2004 Jun; 72(2):149-58. PubMed ID: 15301588 [TBL] [Abstract][Full Text] [Related]
13. Suppression of delayed hypersensitivity skin reactions to tuberculin by M. leprae antigens in patients with lepromatous and tuberculoid leprosy. Sengupta U; Sinha S; Ramu G; Lamb J; Ivanyi J Clin Exp Immunol; 1987 Apr; 68(1):58-64. PubMed ID: 3308210 [TBL] [Abstract][Full Text] [Related]
14. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients. Mutis T; Kraakman EM; Cornelisse YE; Haanen JB; Spits H; De Vries RR; Ottenhoff TH J Immunol; 1993 May; 150(10):4641-51. PubMed ID: 8482851 [TBL] [Abstract][Full Text] [Related]
15. Restoration of proliferative response to M. leprae antigens in lepromatous T cells against candidate antileprosy vaccines. Mustafa AS Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):257-67. PubMed ID: 8862259 [TBL] [Abstract][Full Text] [Related]
16. Analysis of T-cell and B-cell responses to recombinant M. leprae antigens in leprosy patients and in healthy contacts: significant T-cell responses to antigens in M. leprae nonresponders. Thole JE; Janson AA; Kifle A; Howe RC; McLean K; Nurilygn A; Filley E; Shannon EJ; Bulla GJ; Hermans J Int J Lepr Other Mycobact Dis; 1995 Sep; 63(3):369-80. PubMed ID: 7594920 [TBL] [Abstract][Full Text] [Related]
17. Role of macrophages in defective cell mediated immunity in lepromatous leprosy. I. Factor(s) from macrophages affecting protein synthesis and lymphocyte transformation. Salgame PR; Birdi TJ; Mahadevan PR; Antia NH Int J Lepr Other Mycobact Dis; 1980 Jun; 48(2):172-7. PubMed ID: 7190553 [TBL] [Abstract][Full Text] [Related]
18. Associations between HLA-DRB1 alleles and leprosy in an Indonesian population. Soebono H; Giphart MJ; Schreuder GM; Klatser PR; de Vries RR Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):190-6. PubMed ID: 9251590 [TBL] [Abstract][Full Text] [Related]
19. Role of macrophages in defective cell mediated immunity in lepromatous leprosy. II. Macrophage and lymphocyte interaction. Birdi TJ; Salgame PR; Mahadevan PR; Antia NH Int J Lepr Other Mycobact Dis; 1980 Jun; 48(2):178-82. PubMed ID: 6967461 [TBL] [Abstract][Full Text] [Related]
20. Lymphoproliferative responses of leprosy patients and healthy controls to nitrocellulose-bound M. leprae antigens. Sachdeva G; Kaur G; Bhutani LK; Bamezai RN Int J Lepr Other Mycobact Dis; 1999 Jun; 67(2):133-42. PubMed ID: 10472365 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]